Inhibiting DGAT1 by A-922500 alters lipid homeostasis and increases acylcarnitine levels, inducing mitochondrial damage and oxidative stress, and triggering apoptosis in glioblastoma cells. Here, DGAT1 is linked to glioblastoma.